Peptide Libraray

SEQ ID NO: 111 of Patent CN110785183A

General Information

DCTPep ID DCTPep06394

Peptide Name SEQ ID NO: 111 of Patent CN110785183A

Sequence ALCLLLHLL

Sequence Length 9

UniProt ID Not available

PubChem CID Not available

Origin Synthetic

Type Synthetic peptide

Classification

ACP Cancer targeted peptides Immunotherapeutic peptides

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target HLA-A*02

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Linear

Disulfide/Other Bond Not available

N-terminal Modification Free

C-terminal Modification Free

Other Modification None

Chiral L

Physicochemical Information

Formula C48H85N11O10S1

Absent amino acids DEFGIKMNPQRSTVWY

Theoretical pI 6.78

Acidic residues 0

Basic residues 1

Polar residues 1

Molecular weight (Average) 1008.33

Molecular weight (Monoisotopic) 1007.62

Common amino acids L

Net charge 1

Instability index (II) 30.29

Aliphatic index 271.11

Grand average of hydropathicity (GRAVY) 2.656

Half Life
4.4 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 0
Abs 0.1% (=1 g/l) 0.000, assuming all pairs of Cys residues form cystines
Ext. coefficient 0
Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID CN110785183A

Patent Title Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers

Other Iinformation Not available

Other Published ID Not available